Cytogenetics and the biologic basis of sarcomas

Stephen X. Skapek, Chan Hon Chui

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In this past year, a large number of reports have described cytogenetic and biologic studies of sarcomas. The cytogenetic studies provide further evidence that a growing number of sarcomas seem to be defined by consistent chromosomal abnormalities that can be detected using a variety of molecular genetic tests. However, in addition to these specific abnormalities, many sarcomas have other extremely complex genetic changes. This complexity has made it quite difficult to understand the importance of any single abnormality. Laboratory studies complementing these genetic studies have provided further understanding of sarcoma cellular and molecular biology. Importantly, both types of studies have had significant impact in the clinic in the form of more objective diagnostic tests, potential novel prognostic markers, and even new therapeutic strategies. Together, these papers highlight how genetic studies may offer tremendous insight into sarcoma biology. However, they also highlight some limitations of these approaches as well. Novel experimental approaches may be required to facilitate the continued progress in this field toward the development of better therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)315-322
Number of pages8
JournalCurrent Opinion in Oncology
Volume12
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Cytogenetics
Sarcoma
Molecular Biology
Routine Diagnostic Tests
Chromosome Aberrations
Cell Biology
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Cytogenetics and the biologic basis of sarcomas. / Skapek, Stephen X.; Chui, Chan Hon.

In: Current Opinion in Oncology, Vol. 12, No. 4, 2000, p. 315-322.

Research output: Contribution to journalArticle

Skapek, Stephen X. ; Chui, Chan Hon. / Cytogenetics and the biologic basis of sarcomas. In: Current Opinion in Oncology. 2000 ; Vol. 12, No. 4. pp. 315-322.
@article{265365fc6dff4e8c93b43410531be9c1,
title = "Cytogenetics and the biologic basis of sarcomas",
abstract = "In this past year, a large number of reports have described cytogenetic and biologic studies of sarcomas. The cytogenetic studies provide further evidence that a growing number of sarcomas seem to be defined by consistent chromosomal abnormalities that can be detected using a variety of molecular genetic tests. However, in addition to these specific abnormalities, many sarcomas have other extremely complex genetic changes. This complexity has made it quite difficult to understand the importance of any single abnormality. Laboratory studies complementing these genetic studies have provided further understanding of sarcoma cellular and molecular biology. Importantly, both types of studies have had significant impact in the clinic in the form of more objective diagnostic tests, potential novel prognostic markers, and even new therapeutic strategies. Together, these papers highlight how genetic studies may offer tremendous insight into sarcoma biology. However, they also highlight some limitations of these approaches as well. Novel experimental approaches may be required to facilitate the continued progress in this field toward the development of better therapeutic strategies.",
author = "Skapek, {Stephen X.} and Chui, {Chan Hon}",
year = "2000",
doi = "10.1097/00001622-200007000-00007",
language = "English (US)",
volume = "12",
pages = "315--322",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cytogenetics and the biologic basis of sarcomas

AU - Skapek, Stephen X.

AU - Chui, Chan Hon

PY - 2000

Y1 - 2000

N2 - In this past year, a large number of reports have described cytogenetic and biologic studies of sarcomas. The cytogenetic studies provide further evidence that a growing number of sarcomas seem to be defined by consistent chromosomal abnormalities that can be detected using a variety of molecular genetic tests. However, in addition to these specific abnormalities, many sarcomas have other extremely complex genetic changes. This complexity has made it quite difficult to understand the importance of any single abnormality. Laboratory studies complementing these genetic studies have provided further understanding of sarcoma cellular and molecular biology. Importantly, both types of studies have had significant impact in the clinic in the form of more objective diagnostic tests, potential novel prognostic markers, and even new therapeutic strategies. Together, these papers highlight how genetic studies may offer tremendous insight into sarcoma biology. However, they also highlight some limitations of these approaches as well. Novel experimental approaches may be required to facilitate the continued progress in this field toward the development of better therapeutic strategies.

AB - In this past year, a large number of reports have described cytogenetic and biologic studies of sarcomas. The cytogenetic studies provide further evidence that a growing number of sarcomas seem to be defined by consistent chromosomal abnormalities that can be detected using a variety of molecular genetic tests. However, in addition to these specific abnormalities, many sarcomas have other extremely complex genetic changes. This complexity has made it quite difficult to understand the importance of any single abnormality. Laboratory studies complementing these genetic studies have provided further understanding of sarcoma cellular and molecular biology. Importantly, both types of studies have had significant impact in the clinic in the form of more objective diagnostic tests, potential novel prognostic markers, and even new therapeutic strategies. Together, these papers highlight how genetic studies may offer tremendous insight into sarcoma biology. However, they also highlight some limitations of these approaches as well. Novel experimental approaches may be required to facilitate the continued progress in this field toward the development of better therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=0034509424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034509424&partnerID=8YFLogxK

U2 - 10.1097/00001622-200007000-00007

DO - 10.1097/00001622-200007000-00007

M3 - Article

C2 - 10888416

AN - SCOPUS:0034509424

VL - 12

SP - 315

EP - 322

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 4

ER -